RNA-based virome discovery platform that identifies insect-specific viruses (ISVs) in western flower thrips (Frankliniella occidentalis) for development as targeted biocontrol agents. Leverages ribosomal RNA-depleted deep sequencing across diverse populations to uncover novel viral candidates that can be engineered to suppress thrips fitness and vector competence.
Western flower thrips (Frankliniella occidentalis) is one of the most destructive crop pests worldwide and a super-vector of plant viruses that cause major economic losses across vegetables, ornamentals, and field crops. This program applies metagenomic virome discovery to identify insect-specific viruses (ISVs) that naturally replicate only in thrips and are transmitted to their progeny. These ISVs represent a promising, targeted approach to biologically control WFT populations and reduce their ability to transmit crop diseases, offering an alternative or complement to chemical insecticides.
The value proposition for partners is access to a curated pipeline of novel ISV candidates sourced from geographically and host-diverse WFT populations, along with the genomic and phylogenetic characterization needed to prioritize candidates for downstream genetic engineering aimed at suppressing thrips fitness and/or vector competence.
Discovery approach:
Sample scope:
Deliverables:
This is an early-stage discovery and validation program (TRL 3–4). The team has generated foundational RNAseq resources from WFT developmental stages and tissues and is now expanding into comprehensive rRNA-depleted sequencing to capture the full viral diversity, including non-poly(A) genomes. Field sampling during the 2021 season across North Carolina and California populations will provide the ecological breadth needed to identify broadly distributed and novel ISV candidates. Downstream genetic modification of selected ISVs for biocontrol applications represents the next phase of development and would benefit from partners with expertise in insect transformation, regulatory science, and biocontrol product development.
North Carolina State University is a large, comprehensive public land‑grant research university in Raleigh. Its on‑campus research and technology park co‑locates corporate R&D groups, government partners, and faculty labs, enabling shared facilities, prototyping, and agile contracting. Located in North Carolina’s Research Triangle, partners tap a dense regional ecosystem while engaging through a statewide extension network and a mature co‑op program that deliver field deployment and workforce pipelines. Multiple pilot and demonstration facilities support scale‑up and validation toward pre‑commercial readiness. Research is supported by competitive funding from major federal agencies, including NSF, USDA, DOE, and DOD, and a dedicated technology transfer office with clear IP pathways helps accelerate commercialization.